Navigating a Global Marketplace: Managing the Manufacturing, Sales and Distribution of Drugs and Medical Devices by Being Vigilant of the Latest Anti-Corruption Pitfalls
Maura K. Monaghan
Partner
Debevoise & Plimpton LLP
Katherine DeKam
Chief Compliance Officer – Director of Compliance
Acumed, LLC
Michael Russell Clarke
VP, Ethics & Compliance – Americas
Actavis, Inc.
Parth Chanda
Assistant General Counsel, Anti-Corruption Program
Pfizer Inc
Marco A. Gonzalez Jr.
Partner
Nicoll Davis & Spinella LLP
- China: Lessons learned from recent anti-corruption enforcement actions
- Overseas Training: Addressing FCPA and global anticorruption standards with your overseas sales force
- Vetting criteria to determine who might be more compliant
- Dealing with 3rd party intermediaries
- Best practices for minimizing risks
- Best practices for due diligence in vetting consultants, manufacturers, and vendors in high risk markets
- Competing against local companies in cultures where gift giving is the norm
- Establishing preventative internal controls measures to prevent and detect corruption